.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Mesenchymal stromal cells (MSCs) play a pivotal role in modern regenerative medicine. However, obesity significantly compromises the metabolic health and reparative capacity of these cells. Researchers have recently focused on MOTS-c in mesenchymal cells to see if this mitochondrial-derived peptide can reverse these deficits. MOTS-c is well-known for its ability to regulate systemic metabolism and improve insulin sensitivity in various tissues.
The study compared MSCs isolated from the abdominal fat of obese individuals and lean donors. Initially, the researchers found that treating these cells with MOTS-c successfully activated critical metabolic signaling pathways. Specifically, the peptide enhanced mitochondrial oxygen consumption and boosted ATP production within the cells from obese donors. Furthermore, this metabolic reprogramming suggests that the peptide effectively targets the bioenergetic deficiencies typically seen in high-BMI patients.
Despite the metabolic improvements, the results regarding functional repair were surprising. While the peptide optimized energy pathways, it simultaneously blunted the reparative function of the MSCs. Specifically, treated cells exhibited a marked decrease in migratory ability and a reduced capacity for wound healing. Consequently, the study demonstrates a complex trade-off where improved cellular metabolism does not automatically translate into enhanced therapeutic efficacy.
These findings suggest that clinicians must approach mitochondrial-targeted therapies with caution. In the context of obesity, simply restoring energy levels in MOTS-c in mesenchymal cells might not be enough to restore their full regenerative potential. Notably, future research must identify how to decouple metabolic signaling from the pathways that govern cell migration and tissue repair. This balance is essential for developing effective stem-cell-based treatments for patients with metabolic disorders.
MOTS-c activates pathways that increase mitochondrial respiration and ATP production, helping to overcome the metabolic fatigue often found in cells from obese individuals.
Research indicates that while MOTS-c improves energy metabolism, it may interfere with the signaling mechanisms necessary for cell migration and tissue reconstruction, though the exact pathways remain under study.
It highlights that metabolic restoration is only one part of the puzzle. Effective therapy requires ensuring that cells not only have enough energy but also maintain their ability to move to and repair injured tissues.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Xing L et al. Mitochondrial-derived peptide MOTS-c activates metabolic signaling but blunts reparative function in human mesenchymal stromal cells. Inflamm Regen. 2026 Jun 22. doi: 10.1186/s41232-026-00431-7. PMID: 42324588.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A recent study investigates the mitochondrial peptide MOTS-c and its effect on mesenchymal stromal cells (MSCs) from obese donors. While MOTS-c improves metabolic signaling, it unexpectedly hinders the cells' ability to repair tissue, challenging current regenerative medicine assumptions.
4 months ago
Depemokimab offers twice-yearly dosing for severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps, significantly cutting exacerbations and hospital admissions.
3 days back
A novel copper metal-organic framework hydrogel remodels the uterine microenvironment to stimulate robust endometrial regeneration, reduce intrauterine fibrosis, and restore reproductive fertility, offering a groundbreaking strategy for managing refractory endometrial damage and Asherman syndrome.
3 days back
New research reveals that non-ablative radiotherapy suppresses ventricular tachycardia by increasing conduction velocity via NaV1.5 upregulation and action potential prolongation. However, sustained sodium current elevation and depressed calcium handling highlight the need for careful clinical translation.
5 days back
A single-cell transcriptomic atlas reveals how peripheral nerve injuries cause dorsal root ganglion remodeling. By evaluating proximal nerve crush and resection, researchers identify distinct glial and immune programs that resolve neuropathic pain and promote regeneration.
3 days back
A breakthrough study demonstrates that fullerol-primed extracellular vesicles generated in a 3D SECCS bioreactor attenuate ferroptosis and restore myogenic regeneration in diabetes via the FOXO3 pathway, offering a cell-free therapeutic strategy for diabetic musculoskeletal degeneration.
3 days back
